These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 24353913)
1. APLP2 regulates the expression of MHC class I molecules on irradiated Ewing's sarcoma cells. Peters HL; Yan Y; Solheim JC Oncoimmunology; 2013 Oct; 2(10):e26293. PubMed ID: 24353913 [TBL] [Abstract][Full Text] [Related]
2. Specificity of amyloid precursor-like protein 2 interactions with MHC class I molecules. Tuli A; Sharma M; Naslavsky N; Caplan S; Solheim JC Immunogenetics; 2008 Jun; 60(6):303-13. PubMed ID: 18452037 [TBL] [Abstract][Full Text] [Related]
3. Monocyte Maturation Mediators Upregulate CD83, ICAM-1 and MHC Class 1 Expression on Ewing's Sarcoma, Enhancing T Cell Cytotoxicity. Biele E; Schober SJ; Prexler C; Thiede M; Heyking KV; Gassmann H; Eck J; Xue B; Burdach S; Thiel U Cells; 2021 Nov; 10(11):. PubMed ID: 34831294 [TBL] [Abstract][Full Text] [Related]
4. Amyloid precursor-like protein 2 association with HLA class I molecules. Tuli A; Sharma M; Wang X; Simone LC; Capek HL; Cate S; Hildebrand WH; Naslavsky N; Caplan S; Solheim JC Cancer Immunol Immunother; 2009 Sep; 58(9):1419-31. PubMed ID: 19184004 [TBL] [Abstract][Full Text] [Related]
5. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance. Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047 [TBL] [Abstract][Full Text] [Related]
6. Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro. Chansky HA; Barahmand-Pour F; Mei Q; Kahn-Farooqi W; Zielinska-Kwiatkowska A; Blackburn M; Chansky K; Conrad EU; Bruckner JD; Greenlee TK; Yang L J Orthop Res; 2004 Jul; 22(4):910-7. PubMed ID: 15183454 [TBL] [Abstract][Full Text] [Related]
7. Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma. Ban J; Jug G; Mestdagh P; Schwentner R; Kauer M; Aryee DN; Schaefer KL; Nakatani F; Scotlandi K; Reiter M; Strunk D; Speleman F; Vandesompele J; Kovar H Oncogene; 2011 May; 30(18):2173-80. PubMed ID: 21217773 [TBL] [Abstract][Full Text] [Related]
9. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma. Kinsey M; Smith R; Lessnick SL Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343 [TBL] [Abstract][Full Text] [Related]
10. Amyloid precursor-like protein 2 suppresses irradiation-induced apoptosis in Ewing sarcoma cells and is elevated in immune-evasive Ewing sarcoma cells. Peters HL; Yan Y; Nordgren TM; Cutucache CE; Joshi SS; Solheim JC Cancer Biol Ther; 2013 Aug; 14(8):752-60. PubMed ID: 23792571 [TBL] [Abstract][Full Text] [Related]
11. A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells. Girnita L; Girnita A; Wang M; Meis-Kindblom JM; Kindblom LG; Larsson O Oncogene; 2000 Aug; 19(37):4298-301. PubMed ID: 10980604 [TBL] [Abstract][Full Text] [Related]
12. High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition. Awad O; Yustein JT; Shah P; Gul N; Katuri V; O'Neill A; Kong Y; Brown ML; Toretsky JA; Loeb DM PLoS One; 2010 Nov; 5(11):e13943. PubMed ID: 21085683 [TBL] [Abstract][Full Text] [Related]
14. Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts. Ouchida M; Ohno T; Fujimura Y; Rao VN; Reddy ES Oncogene; 1995 Sep; 11(6):1049-54. PubMed ID: 7566963 [TBL] [Abstract][Full Text] [Related]
15. EWS Knockdown and Taxifolin Treatment Induced Differentiation and Removed DNA Methylation from p53 Promoter to Promote Expression of Puma and Noxa for Apoptosis in Ewing's Sarcoma. Hossain MM; Ray SK J Cancer Ther; 2014 Oct; 5(12):1092-1113. PubMed ID: 27547487 [TBL] [Abstract][Full Text] [Related]
16. Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma. Lin PP; Brody RI; Hamelin AC; Bradner JE; Healey JH; Ladanyi M Cancer Res; 1999 Apr; 59(7):1428-32. PubMed ID: 10197607 [TBL] [Abstract][Full Text] [Related]
17. A polypeptide from the junction region sequence of EWS-FLI1 inhibits Ewing's sarcoma cells, interacts with the EWS-FLI1 and partner proteins. Thangaretnam KP; Gopisetty G; Ramanathan P; Rajkumar T Sci Rep; 2017 Aug; 7(1):7172. PubMed ID: 28775288 [TBL] [Abstract][Full Text] [Related]
18. Implication of Amyloid Precursor-like Protein 2 Expression in Cutaneous Squamous Cell Carcinoma Pathogenesis. Huang X; Yang J; Xi H; Zhang M; Oh Y; Jin Z; Zheng Z In Vivo; 2024; 38(1):399-408. PubMed ID: 38148084 [TBL] [Abstract][Full Text] [Related]
19. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells. García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936 [TBL] [Abstract][Full Text] [Related]
20. EWS/FLI-l peptide-pulsed dendritic cells induces the antitumor immunity in a murine Ewing's sarcoma cell model. Peng W; Huang X; Yang D Int Immunopharmacol; 2014 Aug; 21(2):336-41. PubMed ID: 24861249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]